| Literature DB >> 31728007 |
V Brancato1, C Cavaliere2, M Salvatore1, S Monti1.
Abstract
The importance of Diffusion Weighted Imaging (DWI) in prostate cancer (PCa) diagnosis have been widely handled in literature. In the last decade, due to the mono-exponential model limitations, several studies investigated non-Gaussian DWI models and their utility in PCa diagnosis. Since their results were often inconsistent and conflicting, we performed a systematic review of studies from 2012 examining the most commonly used Non-Gaussian DWI models for PCa detection and characterization. A meta-analysis was conducted to assess the ability of each Non-Gaussian model to detect PCa lesions and distinguish between low and intermediate/high grade lesions. Weighted mean differences and 95% confidence intervals were calculated and the heterogeneity was estimated using the I2 statistic. 29 studies were selected for the systematic review, whose results showed inconsistence and an unclear idea about the actual usefulness and the added value of the Non-Gaussian model parameters. 12 studies were considered in the meta-analyses, which showed statistical significance for several non-Gaussian parameters for PCa detection, and to a lesser extent for PCa characterization. Our findings showed that Non-Gaussian model parameters may potentially play a role in the detection and characterization of PCa but further studies are required to identify a standardized DWI acquisition protocol for PCa diagnosis.Entities:
Mesh:
Year: 2019 PMID: 31728007 PMCID: PMC6856159 DOI: 10.1038/s41598-019-53350-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Example of fitted curve of diffusion weighted imaging (DWI) signal against the b-values. According to Gaussian model, when plotted against the b-values, the diffusion magnetic resonance (MR) signal () would follow a straight line whose slope is the ADC (apparent diffusion coefficient). Non-Gaussian DWI models were introduced to describe the deviation of measured data from this expected line. Abbreviations: DWI, diffusion weighted imaging.
Article classifications according to the Non-Gaussian model examined and the diagnostic purpose of the study. Abbreviations: PCa, prostate cancer.
| Classification based on Non-Gaussianmodels | Classification based on PCa diagnosis |
|---|---|
| Intravoxel Incoherent Motion Model ( | PCa detection |
| Biexponential Model ( | Characterization of PCa aggressiveness |
| Stretched Exponential Model ( | |
| Diffusion Kurtosis Imaging ( |
Figure 2Scheme reporting planning of the study. Abbreviations: DWI, Diffusion Weighted Imaging; IVIM, Intravoxel Incoherent Motion model; BE, Biexponential model; SE, Stretched Exponential model; DKI, Diffusion Kurtosis Imaging.
Figure 3PRISMA flow diagram of the study selection procedure. Abbreviations: DWI, Diffusion Weighted Imaging; IVIM, Intravoxel Incoherent Motion model; BE, Biexponential model; SE, Stretched Exponential model; DKI, Diffusion Kurtosis Imaging; BPH, benign prostatic hypertropia; SD, standard deviation; GS, Gleason Score; ROI, region of interest.
Selected studies for qualitative and quantitative analysis.
| Author | Year | Non-Gaussian Models | Purpose (D/C) | Sd | No. of PCa patients | No. of PCa regions | No. of NT regions | No. of Low GS regions (<=6) | No. of High GS regions (>6) | Included | Reasons for exclusion from MA |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shinmoto | 2012 | IVIM | D | R | 26 | N/E | N/E | — | — | No | Study on IVIM model |
| Liu | 2013 | BE | D | P | 23 | N/E | N/E | — | — | No | Study on BE model |
| Kuru | 2014 | IVIM | D, C | R | 27 | N/E | N/E | N/E | N/E | No | Study on IVIM model |
| Zhang | 2015 | IVIM | C | R | 48 | — | — | N/E | N/E | No | Study on IVIM model |
| Martin | 2014 | IVIM | D | R | 36 | N/E | N/E | — | — | No | Study on IVIM model |
| Valerio | 2016 | IVIM | D, C | P | 53 | N/E | N/E | N/E | N/E | No | Study on IVIM model |
| Yang | 2016 | IVIM | C | R | 41 | — | — | N/E | N/E | No | Study on IVIM model |
| Barbieri | 2017 | IVIM | C | P | 84 | — | — | N/E | N/E | No | Only analysis of correlation with GS reported |
| Bao | 2017 | IVIM | C | P | 30 | — | — | N/E | N/E | No | Only analysis of correlation with GS reported |
| Pesapane | 2017 | IVIM | D, C | P | 31 | N/E | N/E | N/E | N/E | No | Study on IVIM model |
| Liu | 2015 | SE | D | P | 27 | 31 | 62 | — | — | Yes | |
| Liu | 2018 | SE | C | R | 75 | — | — | N/E | N/E | Yes | |
| Rosenkrantz | 2012 | DKI | D, C | R | 47 | 121 | 47 | 51 | 70 | Yes | |
| Tamura | 2014 | DKI | D | R | 20 | 24 | 20 | — | — | Yes | |
| Suo | 2014 | DKI | D, C | R | 19 | 19 | 19 | 9 | 10 | Yes | |
| Roethke | 2015 | DKI | D, C | R | 55 | 55 | 55 | 12 | 43 | Yes | |
| Wang | 2015 | DKI | C | R | 110 | — | — | 49 | 77 | Yes | |
| Tamada | 2017 | DKI | D, C | R | 285 | 285 | 285 | 73 | 311 | Yes | |
| Wang | 2018 | DKI | C | R | 67 | — | — | N/E | N/E | No | b = 0 not included in DWI protocol |
| Quentin | 2012 | IVIM | D | P | 8 | N/E | N/E | — | — | No | Study on IVIM model |
| Mazzoni | 2014 | IVIM, DKI | D | R | 57 | 73 | 45 | — | — | Yes | Exclusion of IVIM model |
| Ueda | 2016 | IVIM | D | R | 63 | 64 | 64 | — | — | No | Study on IVIM model |
| Jambor | 2015 | BE, DKI, SE | D | P | 16 | N/E | N/E | — | — | No | Mean - SD values not reported |
| Toivonen | 2015 | BE, DKI, SE | D, C | P | 50 | N/E | N/E | N/E | N/E | No | Mean - SD values notreported |
| Feng | 2017 | IVIM, DKI, SE | D | P | 56 | 138 | 198 | — | — | Yes | Exclusion of IVIM model |
| Barrett | 2017 | DKI | D, C | P | 30 | N/E | N/E | N/E | N/E | No | Mean - SD values notreported |
| Merisaari | 2017 | IVIM, SE | D, C | P | 81 | N/E | N/E | N/E | N/E | No | Mean - SD values not reported |
| Mazaheri | 2018 | BE, DKI, SE | D | R | 55 | 55 | 55 | — | — | Yes | Exclusion of BE model |
| Langkilde | 2018 | BE, DKI, SE | D, C | R | 40 | 40 | 111 | N/A | N/A | Yes | Exclusion of BE model |
Abbreviations: IVIM, Intravoxel Incoherent Motion Model; BE, Biexponential Model; DKI, Diffusion Kurtosis Imaging; SE, Stretched Exponential Model; D, detection; C, characterization; Sd, study design; P, prospective; R, retrospective; PCa, prostate cancer; NT, normal tissue; GS, Gleason Score; MA, meta-analysis; SD, standard deviation; N/E, not extracted because not necessary for quantitative analysis; —, non-existent. Notes: the number of PCa regions, Low GS regions and High GS regions were reported as sum of all PCa, Low GS or High GS regions respectively, regardless of the affected prostate zone (peripheral zone, transition zone, central gland); the number of NT regions were reported as sum of all NT regions, regardless of the affected prostate zone and the patient on which the ROI was placed (e.g. healthy volunteer, PCa patient). The column “Reason for exclusion from MA” reported the reason why the study under investigation, or which analyzed model, was excluded from the meta-analysis. As regards IVIM and BE models, they were excluded from meta-analysis due to heterogeneity in fitting functions/procedures among selected studies and this was indicated by the sentences “Study on IVIM model” or “Study on BE model”, if the study included only these models, “Exclusion of IVIM model” or “Exclusion of BE model”, if the study reported other Non-Gaussian DWI models that were, instead, retained into meta-analysis.
Imaging characteristics.
| Author | FS [T] | TR/TE | Seq. | b-values [s/mm2] | Non-Gaussian fitting function(s) | Non-Gaussian Parameters | Fitting procedure | Initialization values | Methods to prevent finding local minima |
|---|---|---|---|---|---|---|---|---|---|
| Shinmoto | 3.0 | 5132/40 | NR | 0, 10, 20, 30, 50, 80, 100, 200, 400, 1000 | S(b)/S0 = (1-f)∙exp(−b∙D) + f∙exp(−b∙(D* + D)) | D, D*, f | NR | NR | NR |
| Liu | 3.0 | 4000/71.9 | SS-EPI | For ADC: 0, 1000; For BE: 0, 300, 600, 900, 1200, 1500, 1800, 2100, 2400, 2700, 3000 | S(b)/S0 = fslow∙exp(−b∙Dslow) + ffast∙exp(−b∙Dfast) | Dslow, Dfast, f | NR | NR | NR |
| Kuru | 3.0 | 3100/52 | SS-EPI | 0, 50, 100, 150, 200, 250, 800 | S(b)/S0 = (1-f)∙exp(−b∙D) + f∙exp(−b∙(D* + D)) | M1: D, D*, f M2: D, f | M1: SLF for D and f, NLRF for D*; M2: BeF using LMa with D* fixed to 20 µm[ | NR | NR |
| Zhang | 3.0 | 6000/72 | SS-EPI | 0, 50, 150, 300, 600, 900 | S(b)/S0 = (1-f)∙exp(−b∙D) + f∙exp(−b∙D*) | D, D*, f | BeF using LMa | NR | NR |
| Martin | 3.0 | 5000/54 | SS-EPI | 0, 20, 40, 100, 300, 500, 1000, 2000 | S(b)/S0 = (1-f)∙exp(−b∙D) + f∙exp(−b∙(D* + D)) | D, f | NR | NR | NR |
| Valerio | 3.0 | 3100/102 | NR | For ADC: 0, 500, 1000, 3000; For IVIM: 0, 10, 20, 30, 40, 50, 80, 100, 200, 400, 800 | S(b)/S0 = (1-f)∙exp(−b∙D) + f∙exp(−b∙D*) | D, D*, f | NR | D: [0–10]∙10−3 mm2/s D*: [10–150]∙10−3 mm2/s f: [0–1] | NR |
| Yang | 3.0 | 5000/90 | SS-EPI | 0, 10, 20, 50, 100, 200, 500, 800 | S(b)/S0 = (1-f)∙exp(−b∙D) + f∙exp(−b∙D*) | D, D*, f | BeF using LMa | NR | NR |
| Barbieri | 3.0 | 2600/58 | SS-EPI | 0, 10, 20, 50, 130, 270, 500, 900 | S(b)/S0 = (1-f)∙exp(−b∙D) + f∙exp(−b∙D*) | D, D*, f | Bpb | NR | NR |
| Bao | 3.0 | 6800/98 | SS-EPI | 0, 50, 100, 150, 200, 500, 1000 | S(b)/S0 = (1-f)∙exp(−b∙D) + f∙exp(−b∙D*) | D, D*, f | NR | NR | NR |
| Pesapane | 1.5 | 7000/10 | SS-EPI | For ADC: 0, 1000, 2000; For IVIM: 0, 10, 20, 30, 50, 80, 100, 200, 400, 800 | S(b)/S0 = (1-f)∙exp(−b∙D) + f∙exp(−b∙(D* + D)) | D, D*, f | NR | NR | NR |
| Liu | 3.0 | 4000/71.9 | SS-EPI | 0, 500, 1000, 2000 | S(b)/S0 = exp[−(b∙DDC)α] | DDC, α | NR | — | NR |
| Liu | 3.0 | 4000/71.9 | SS-EPI | 0, 500, 1000, 2000 | S(b)/S0 = exp[−(b∙DDC)α] | DDC, α | NR | — | NR |
| Rosenkrantz | 3.0 | 3500/81 | SS-EPI | 0, 500, 1000, 1500, 2000 | S(b)/S0 = exp(−b∙DK + b2∙DK2∙K/6) | DK, K | NR | — | NR |
| Tamura | 3.0 | 5000/49 | SS-EPI | 0, 10, 20, 30, 50, 80, 100, 200, 400, 1000, 1500 | S(b)/S0 = exp(−b∙DK + b2∙DK2∙K/6) | DK, K | NR | — | NR |
| Suo | 3.0 | 3940/106 | SS-EPI | 0, 500, 800, 1200, 1500, 2000 | S(b)/S0 = exp(−b∙DK + b2∙DK2∙K/6) | DK, K | NLLS | — | NR |
| Roethke | 3.0 | For ADC: 3100/52 For DKI: 2700/70 | SS-EPI | For ADC: 0, 800 For DKI: 0, 50, 250, 500, 750, 1000, 1250, 1500, 2000 | S(b)/S0 = exp(−b∙DK + b2∙DK2∙K/6) | DK, K | LMa | — | NR |
| Wang | 3.0 | 6800/98 | SS-EPI | 0, 700, 1400, 2100 | S(b)/S0 = exp(−b∙DK + b2∙DK2∙K/6) | DK, K | NR | — | NR |
| Tamada | 3.0 | 3500/81 | SS-EPI | For ADC: 0, 1000 For DKI: 0, 500, 1000, 1500, 2000” | S(b)/S0 = exp(−b∙DK + b2∙DK2∙K/6) | K | NR | — | NR |
| Wang | 3.0 | 4500/95 | SS-EPI | 200, 500, 1000, 1500, 2000 | S(b)/S0 = exp(−b∙DK + b2∙DK2∙K/6) | K | NR | — | NR |
| Quentin | 3.0 | 2600/89 | SS-EPI | 0, 50, 100, 150, 200, 300, 400, 500, 600, 700, 800 | S(b)/S0 = (1-f)∙exp(−b∙D) + f∙exp(−b∙(D* + D)) | D, D*, f | NR | NR | NR |
| Mazzoni | 3.0 | 2100/69 | SS-EPI | 0, 50, 100, 150, 200, 250, 400, 650, 800, 1000, 1400, 1800, 2300 Different ranges used: 0–2300 (group A); 0–1800 (group B); 0–800 (group C) | IVIM: S(b)/S0 = (1-f)∙exp(−b∙D) + f∙exp(−b∙D*) DKI: S(b)/S0 = exp(−b∙DK + b2∙DK2∙K/6) | D, D*, f, DK, K | NR | NR | NR |
| Ueda | 3.0 | 4000/65 | SS-EPI | 0, 50, 100, 200, 500, 1000, 2000, 3000 | S(b)/S0 = (1-f)∙exp(−b∙D) + f∙exp(−b∙D*) | D, D*, f | SLF for D | NR | NR |
| Jambor | 3.0 | 3141/51 | SS-EPI | For HV: 0, 50, 100, 200, 350, 500, 650, 800, 950, 1100, 1250, 1400, 1550, 1700, 1850, 2000 For PCa patients: 0, 100, 300, 500, 700, 900, 1100, 1300, 1500, 1700, 1900, 2000 | BE: S(b)/S0 = fslow∙exp(−b∙Dslow) + ffast∙exp(−b∙Dfast) DKI: S(b)/S0 = exp(−b∙DK + b2∙DK2∙K/6) | Dslow, Dfast, ffast, DK, K, DDC, α | NR | For PCa: Dfast:1.0–9.0 (ss 0.2) µm2/ms Dslow:0.0–4.0 (ss 0.02) µm2/ms f:0.2–1.0 (ss 0.1) For HV: Dfast:1.0–7.0 (ss 0.1) µm2/ms Dslow:0.0–2.0 (ss 0.01) µm2/ms f:0.2–1.0 (ss 0.1) | Multiple initialization values |
| Toivonen | 3.0 | 3141/51 | SS-EPI | 0, 100, 300, 500, 700, 900, 1100, 1300, 1500, 1700, 1900, 2000 | BE: S(b)/S0 = fslow∙exp(−b∙Dslow) + ffast∙exp(−b∙Dfast) DKI: S(b)/S0 = exp(−b∙DK + b2∙DK2∙K/6) | Dslow, Dfast, ffast, DK, K, DDC, α | BeF using LMa | Dfast:1.0–9.0 (ss 0.2) µm2/ms Dslow:0.0–4.0 (ss 0.02) µm2/ms f:0.2–1.0 (ss 0.1) | Multiple initialization values |
| Feng | 3.0 | 2500/84.1 | SS-EPI | 0, 20, 50, 80, 100, 150, 200, 400, 600, 800, 1000, 1200, 1500, 1800, 2000, 2400, 2800, 3200, 3600, 4000, 4500 Different ranges used: 0–1000; 0–2000; 0–3200; 0–4500 | DKI: S(b)/S0 = exp(−b∙DK + b2∙DK2∙K/6) SE: S(b)/S0 = exp[−(b∙DDC)α] | D, D*, f, DK, K, DDC, α | BeF using LMa | NR | NR |
| Barrett | 3.0 | For DWI: 4000/70–75 For DKI: 6000/94 | SS-EPI | For ADC: 0, 150, 1000, 1400; For DKI: 0, 150, 450, 800, 1150, 1500 | S(b)/S0 = exp(−b∙DK + b2∙DK2∙K/6) | DK, K | NR | — | NR |
| Merisaari | 3.0 | 1394/44 | SS-EPI | 0, 2, 4, 6, 9, 12, 14, 18, 23, 28, 50, 100, 300, 500 | IVIM: S(b)/S0 = (1-f)∙exp(−b∙D) + f∙exp(−b∙D*) SE: S(b)/S0 = exp[−(b∙DDC)α] | D, D*, f, DDC, α | For IVIM: NLLS, SM, OSM, NNLS, delta. For DKI and SE: LMa | NLLS: D:0.01–3.5 (ss 0.1) µm2/ms D*:0.1–28.0 (ss 1.0) µm2/ms f:0.001–0.25 (ss 0.01) SM, OSM: D:0.01–3.5 (ss 0.1) µm2/ms D*:0.1–25.0 (ss 1.0) µm2/ms f:0.001–0.25 (ss 0.01) NNLS: D:0.01–4.0 (ss 0.02) µm2/ms D*:1–9.0 (ss 0.2) µm2/ms f:0.0–1.0 delta: D:0.01–2.0 (ss 0.02) µm2/ms f:0.001–0.1 | Multiple initialization values |
| Mazaheri | 3.0 | 3000–4000/78.2–80.4 | SS-EPI | 0, 600, 800, 1000, 1200, 1400, 1800, 2000 | BE: S(b)/S0 = fslow∙exp(−b∙Dslow) + ffast∙exp(−b∙Dfast) DKI: S(b)/S0 = exp(−b∙DK + b2∙DK2∙K/6) SE: S(b)/S0 = exp[−(b∙DDC)α] | Dslow, Dfast, ffast, DK, K, DDC, α | BeF using LMa | NR | |
| Langkilde | 3.0 | 4000/~100 | NR | 0, 250, 500, 750, 1000, 1250, 1500, 1750, 2000, 2250, 2500, 2750, 3000, 3250, 3500 | BE: S(b)/S0 = fslow∙exp(−b∙Dslow) + ffast∙exp(−b∙Dfast) DKI: S(b)/S0 = exp(−b∙DK + b2∙DK2∙K/6) SE: S(b)/S0 = exp[−(b∙DDC)α] | Dslow, Dfast, ffast, DK, K, DDC, α | BeF using LMa | NR |
Abbreviations: IVIM, Intravoxel Incoherent Motion Model; BE, Biexponential Model; DKI, Diffusion Kurtosis Imaging; SE, Stretched Exponential Model D, molecular diffusion coefficient; D*, pseudo-diffusion coefficient; f, perfusion fraction; Dslow, slow diffusion coefficient; Dfast, fast diffusion coefficient; fslow, amplitude of slow diffusion coefficient; ffast, amplitude of fast diffusion coefficient; DK, diffusion coefficient corrected for kurtosis; K, kurtosis coefficient; DDC, distributed diffusion coefficient; α, heterogeneity index; ADC, apparent diffusion coefficient; FS, field strength; T, Tesla; TR, Repetition Time; TE, Echo Time; ms, milliseconds; Seq., diffusion sequence; HV, healthy volunteers; SS-EPI, Single-Shot Echo-Planar Imaging;BeF, Biexponential Fit; SLF, Simplified Linear Fit; NLRF, Non-Linear Regression Fit; LMa, Levemberg-Marquardt algorithm; Bpb, Bayesian probability-based approach; NNLS, Non Negative Least Square; SM, Segmented Method; OSM, Oversegmented Method; ss, step size; NR, not reported. Diffusion times column was not added because only 4 studies provided this acquisition parameter (see Supplementary Material –S6- for more details).
Figure 4Forest plot showing results on Stretched Exponential Model (SE) parameters for PCa detection: (a) results on distributed diffusion coefficient (DDC) in normal tissue (NT) PCa [mean DDC ± standard deviation (SD) × 10−3 mm2/s]; (b) results on heterogeneity index (α) in NT and PCa [mean α ± SD]. Studies included in the meta-analysis are listed in the column “Study or Subgroup” and, in case of studies considered multiple times, the different b-value ranges and/or outcome measurements are reported in parenthesis. Abbreviations: nPZ, normal peripheral zone; tPZ, tumoral peripheral zone; nTZ, normal transitional zone; tTZ, tumoral transitional zone; nCG, normal central gland.
Figure 5Forest plot showing results on Diffusion Kurtosis Imaging (DKI) model parameters for prostate cancer (PCa) detection: (a) results on kurtosis coefficient (K) in normal tissue (NT) and PCa [mean ± standard deviation (SD) × 10−3 mm2/s]; results on diffusion coefficient corrected for kurtosis (DK) in NT and PCa [mean ± SD × 10−3 mm2/s]. Studies included in the meta-analysis are listed in the column “Study or Subgroup” and, in case of studies considered multiple times, the different b-value ranges and/or outcome measurements are reported in parenthesis. Abbreviations: nPZ, normal peripheral zone; tPZ, tumoral peripheral zone; nTZ, normal transitional zone; tTZ, tumoral transitional zone; PCa_all, all PCa lesions; PCa_GS, PCa lesions with Gleason Score equal to a certain value; PCa_GS+, PCa lesions with Gleason Score greater to a certain value; PCa_GS+ = , PCa lesions with Gleason Score greater or equal to a certain value; ROI, region of interest (ROI)-based fitting approach; PIX, voxel-by-voxel fitting approach; NC, ROI-based fitting approach without noise correction.
Figure 6Forest plot showing results on DKI model parameters for prostate cancer (PCa) characterization: (a) results on diffusion kurtosis (K) in low and high Gleason Score (GS) PCa [mean ± standard deviation (SD) × 10−3 mm2/s]; (b) results on diffusion coefficient corrected for kurtosis (DK) in low and high GS PCa [mean ± SD × 10−3 mm2/s]. Abbreviations: GS, PCa lesions with Gleason Score equal to a certain value; PCa_GS+, PCa lesions with Gleason Score greater to a certain value; ROI, region of interest (ROI)-based fitting approach; PIX, voxel-by-voxel fitting approach; NC, ROI-based fitting approach without noise correction.